Invirsa Funding & Investors
Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury. These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication.
invirsa.comTotal Amount Raised: $16,145,217
Invirsa Funding Rounds
Series B
$7,700,000
Series B Investors
CincyTechJobsOhioRev1 VenturesJumpstart VenturesSeries Unknown
$5,976,217
Series A
$1,800,000
Series A Investors
CincyTechSeed
$520,000
Seed Investors
CincyTechRev1 VenturesConvertible Note
$149,000
Convertible Note Investors
Rev1 Ventures
Funding info provided by Diffbot.